Check-Cap's C-Scan beats reference test in study; shares up 20% premarket [Seeking Alpha]
Check-Cap Ltd. - Ordinary Share (CHEK)
Last check-cap ltd. - ordinary share earnings: 11/6 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.check-cap.com
Company Research
Source: Seeking Alpha
Results from Check-Cap's (NASDAQ: CHEK ) post-CE approval study evaluating the screening performance of C-Scan to detect precancerous polyps in the colon showed much better performance compared to the fecal immunochemical test (FIT). The data were generated from 90 patients who either had known polyps or were considered to be at average risk. Each ingested a C-Scan capsule in additional to undergoing a FIT test and colonoscopy. In patients with polyps at least 10 mm in size, the sensitivity (correctly identifying true positives) of C-Scan was 76% compared to 29% for FIT. C-Scan's specificity (correctly identifying true negatives) was 82% versus 96% for FIT in these patients. In all patients, C-Scan's sensitivity was 66% compared to 23% for FIT. A U.S. pilot study is in process with an estimated completion date in September. A pivotal trial should launch in mid-2020. Update : Shares are up premarket on average volume. See all stocks on the move » Now rea
Show less
Read more
Impact Snapshot
Event Time:
CHEK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CHEK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CHEK alerts
High impacting Check-Cap Ltd. - Ordinary Share news events
Weekly update
A roundup of the hottest topics
CHEK
News
- Check-Cap Ltd. (NASDAQ: CHEK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Check-Cap Ltd. (NASDAQ: CHEK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Check-Cap Ltd. (NASDAQ: CHEK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Check-Cap Ltd. (NASDAQ: CHEK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Check-Cap Ltd. (NASDAQ: CHEK) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat